相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant
Karen Smith Korsholm et al.
VACCINE (2014)
Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: Low-burst release is crucial for efficient CD8+ T cell activation
A. L. Silva et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Antitumor effects obtained by autologous Lewis lung cancer cell vaccine engineered to secrete mouse Interleukin 27 by means of cationic liposome
Junfeng Zhang et al.
MOLECULAR IMMUNOLOGY (2013)
Predicting the efficacy of cancer vaccines by evaluating T-cell responses
Suzanne van Duikeren et al.
ONCOIMMUNOLOGY (2013)
CAF05: cationic liposomes that incorporate synthetic cord factor and poly(I:C) induce CTL immunity and reduce tumor burden in mice
Jon Hansen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Targeting tumor antigens to dendritic cells using particulate carriers
Medha D. Joshi et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Vaccine-Induced Effector-Memory CD8+ T Cell Responses Predict Therapeutic Efficacy against Tumors
Suzanne van Duikeren et al.
JOURNAL OF IMMUNOLOGY (2012)
Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens
Douglas S. Watson et al.
VACCINE (2012)
Toll-like receptor 3 agonist complexed with cationic liposome augments vaccine-elicited antitumor immunity by enhancing TLR3-IRF3 signaling and type I interferons in dendritic cells
Ce Wang et al.
VACCINE (2012)
Liposomes: From a Clinically Established Drug Delivery System to a Nanoparticle Platform for Theranostic Nanomedicine
Wafa' T. Al-Jamal et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles
Shuang Cai et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Cooperativity of adaptive and innate immunity: implications for cancer therapy
Anil Shanker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients
W. Joost Lesterhuis et al.
CLINICAL CANCER RESEARCH (2011)
Immunity by formulation design: Induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method
Pernille Nordly et al.
JOURNAL OF CONTROLLED RELEASE (2011)
The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses
Yifan Ma et al.
NANOSCALE (2011)
Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination
Suzanne M. Bal et al.
VACCINE (2011)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Materials engineering for immunomodulation
Jeffrey A. Hubbell et al.
NATURE (2009)
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows lowtoxicity and robust immunogenicity
Gemma G. Kenter et al.
CLINICAL CANCER RESEARCH (2008)
Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
Martijn S. Bijker et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Non-viral dried powders for respiratory gene delivery prepared by cationic and chitosan loaded liposomes
C. Colonna et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine
Weili Yan et al.
JOURNAL OF CONTROLLED RELEASE (2008)
poly(I:C) and LPS induce distinct IRF3 and NF-κB signaling during type-I IFN and TNF responses in human macrophages
Thornik Reimer et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
CD8+ T cell efficacy in vaccination and disease
Victor Appay et al.
NATURE MEDICINE (2008)
Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines
Cornelis J. M. Melief et al.
NATURE REVIEWS CANCER (2008)
A simple but effective cancer vaccine consisting of an antigen and a cationic lipid
Weihsu Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN
Susan de Jong et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes
Karen Zaks et al.
JOURNAL OF IMMUNOLOGY (2006)
Essential role of mda-5 in type IIFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus
Leonid Gitlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Central memory and effector memory T cell subsets: Function, generation, and maintenance
F Sallusto et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1)
D Voehringer et al.
BLOOD (2002)
Phospholipid-cationic lipid interactions: influences on membrane and vesicle properties
RB Campbell et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity
B Ludewig et al.
VACCINE (2000)
分享论文
